Navigation Links
DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
Date:5/21/2013

Chicago, IL (PRWEB) May 21, 2013

The prescriptin drug resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. A recent study suggests patients taking the drug may be at more risk of death when suffering a head injury than those taking traditional anticoagulants*.

DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional blood thinners. The FDA has stated the drug is as safe as warfarin**. However, the Institute for Safe Medication Practices recently warned that Pradaxa bleeding may be nearly 5 times as likely to result in death than bleeding from warfarin or Coumadin***.

The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.

Now, DrugRisks has learned of a new study published this month in the Journal of Neurosurgery, showing that patients who suffer head trauma while taking Pradaxa are more likely to die of brain hemorrhage than those taking warfarin*.

Due to the number of patients who have filed a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Journal of Neurosurgery, 5/1/13; thejns.org/doi/pdf/10.3171/2013.3.JNS12503
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-bleeding/lawsuit-study-brain/prweb10750534.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
4. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
5. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
6. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
7. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
8. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
9. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
10. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
11. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... , ... METTLER TOLEDO has announced the availability of a ... Tools . , Crystallization is a common step used during the ... now spend more time developing better intermediate and final crystallization steps. By ...
(Date:1/23/2017)... ... January 23, 2017 , ... Old School Labs™, makers ... Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team of brand ambassadors. ... bodybuilder in 2012 and in less than a year was able to turn professional, ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: a moving and eloquent ... life. “Crossing the Bar” is the creation of published author, Charlotte Hotte, a North ... who credits the inspiration of the book to her sister, Denise, wishes to acknowledge ...
(Date:1/23/2017)... ... 2017 , ... Valentine’s Day is a time when many people celebrate romance and love by ... be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a ... Or, spend $200 and get $50 free. , “A lot of people just buy ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals ... of a simple test will take days to arrive to the end customer, having ... direct access to their lab tests, bypassing the cost and delay of traditional means. ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017 A new Transparency Market Research ... was valued at US$0.53 bn in 2013 and is predicted to ... CAGR between 2014 and 2022. The title of the report is ... Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), also referred ...
(Date:1/23/2017)... SAN FRANCISCO , January 23, 2017 The global  ... USD 18.3 billion by 2025. The rising incidence of depression worldwide is anticipated ... and psychotherapies has resulted in the declining demand for antidepressants in the recent ... ... Grand View Research Logo ...
(Date:1/23/2017)... SAN DIEGO , 23. Januar 2017  ResMed ... China ) und 3B Medical ( Winter ... sich auf eine Vereinbarung über die Beilegung aller globalen ... ist der Verkauf ihrer bestehenden Produkte im ... eine einmalige Zahlung an 3B leisten, um das in ...
Breaking Medicine Technology: